Become a student member today for free and be part of the RACGP community
Live and practise medicine in Australia
RACGP offer courses and events to further develop the knowledge you need to develop your GP career
Discover a world of educational opportunities to support your lifelong learning
Become a provider with the CPD Program and be recognised for the quality education and training you offer GPs
The Abuse and violence: working with our patients in general practice provides the best-available current evidence for GPs
Stay up-to-date with the latest information and resources on the COVID-19 vaccine rollout.
Download the Standards for general practice (5th edition) - a benchmark for quality care and risk management in Australian general practices
Coronavirus (COVID-19) resources for general practitioners
Advice and guidelines for GPs and practice teams to help protect general practice information systems
Video consultations can provide convenient and accessible healthcare delivery
Read all of the RACGP reports and submissions on various healthcare topics
Read all of the RACGP position statements on various healthcare topics
Join our RACGP Facebook groups
Winter Planning Toolkit modules
Module 4: Managing patients
Non-medical treatments for patients and staff experiencing virus symptoms include:
Advise patients and staff to avoid the workplace if they have symptoms and remind them of the generic benefits of mask wearing (e.g. reduced influenza as well as COVID-19 transmission).
Two antiviral medicines, Lagevrio (molnupiravir) and Paxlovid© (nirmatrelvir plus ritonavir), were provisionally approved for use in Australia for the treatment of COVID-19 in January 2022. Both are now available via the Pharmaceutical Benefits Scheme (PBS) as Authority Required (Streamlined) items.
Eligible patients are now able to access these medicines from their local pharmacy, where available, with a prescription from their doctor or nurse practitioner.
To support safe and appropriate prescribing of these medicines, the RACGP has published guidance:
Tamiflu© is an oral antiviral used for both post-exposure chemoprophylaxis and to treat Influenza A and B infections.
Tamiflu product information
Did you know you can now log your CPD with a click of a button?
Donate to the RACGP Foundation today and influence the future of general practice